These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5636244)

  • 21. [Serotyping and sulfonamide sensitivity in isolated meningococci 1974-1980. Cases from the Haukeland Hospital].
    Natås OB; Digranes A; Ostervold B
    Tidsskr Nor Laegeforen; 1983 Apr; 103(10):853-5. PubMed ID: 6410536
    [No Abstract]   [Full Text] [Related]  

  • 22. [A sulfanilamide with an extremely slow elimination. Elimination, distribution, dosage and enteric absorption of 4-sulfanilamido-5,6-dimethoxypyrimidine in children].
    Gladtke E
    Klin Wochenschr; 1965 Dec; 43(24):1332-4. PubMed ID: 5896035
    [No Abstract]   [Full Text] [Related]  

  • 23. [New slow-acting sulfonamide in the treatment of chronic asthma].
    Aguirre M; Lahoz F; Jiménez Casado M
    Rev Clin Esp; 1966 Jul; 102(2):105-8. PubMed ID: 5992358
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of urinary tract infections with a new sulfonamide in low dosage].
    Bergfors PG
    Lakartidningen; 1967 Mar; 64():Suppl 1:62-7. PubMed ID: 6042213
    [No Abstract]   [Full Text] [Related]  

  • 25. How drugs act. Six. Drugs at different ages.
    Smith S
    Nurs Times; 1985 Jan 9-15; 81(2):37-9. PubMed ID: 3844191
    [No Abstract]   [Full Text] [Related]  

  • 26. A study of dosage and blood levels of long-acting sulphonamides in pediatric practice.
    Rao PT; Seshachari KR; Venkatesh A
    Indian Pediatr; 1965 Jul; 2(7):266-9. PubMed ID: 5319782
    [No Abstract]   [Full Text] [Related]  

  • 27. [Indications for delayed-action sulfonamide therapy. Adverse effects and complications of sulfonamide therapy].
    Leng-Lévy J; Aubertin J; Leng B; Magendie P; Marion J
    J Med Bord; 1967 Oct; 144(10):1465-88. PubMed ID: 5605725
    [No Abstract]   [Full Text] [Related]  

  • 28. [Intraindividual variations in the elimination rate of drugs].
    Krauer B
    Z Kinderheilkd; 1970; 108(3):231-7. PubMed ID: 5475033
    [No Abstract]   [Full Text] [Related]  

  • 29. Pediatric critical care pharmacodynamics.
    Dionne R; McManus C
    Crit Care Nurs Clin North Am; 1993 Jun; 5(2):367-75. PubMed ID: 8398042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pediatric guiding principles. 1. Introduction. 2. Dosage of antimicrobiotics].
    Ocklitz HW; Schmitz HH; Schmidt EF
    Z Arztl Fortbild (Jena); 1968 Sep; 62(18):1033-40. PubMed ID: 4237439
    [No Abstract]   [Full Text] [Related]  

  • 31. [Electro-clinical and developmental forms of epilepsy as a function of their appearance at different ages of life].
    Gastaut H; Oller-Daurella L
    Acta Neurol Latinoam; 1981; 27(1-2):19-50. PubMed ID: 6965168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Controlled study of 3 sulfonamides in chronic urinary and bronchial infections].
    Piolino M; de Kalbermatten JP; Dobjanski S; Granato D; Schelling JL
    Schweiz Med Wochenschr; 1968 Nov; 98(44):1756-62. PubMed ID: 4884544
    [No Abstract]   [Full Text] [Related]  

  • 33. [23 cases of severe bullous dermatitis medicamentosa with epidermolysis].
    Huriez C; Bergoend H; Bertez ML
    Ann Dermatol Syphiligr (Paris); 1972; 99(5):493-500. PubMed ID: 4267527
    [No Abstract]   [Full Text] [Related]  

  • 34. [Use of new drug treatments in child psychiatry (long-acting neuroleptics, antidepressive agents and lithium)].
    Dugas M; Velin J; Guériot C; Frohwirth C
    Cah Med; 1973 Sep; 14(9):711-6. PubMed ID: 4779496
    [No Abstract]   [Full Text] [Related]  

  • 35. [Quantitative studies on serum IgE level in healthy control subjects of various ages and in patients with hypersensitivity].
    Velcovsky HG; Bürkle PA; Federlin K
    Verh Dtsch Ges Inn Med; 1972; 78():81-4. PubMed ID: 4677226
    [No Abstract]   [Full Text] [Related]  

  • 36. Carrier rate of Neisseria meningitidis and the occurrence of sulfonamide resistant strains in Lebanon.
    Uwaydah M
    J Med Liban; 1973; 26(5):495-500. PubMed ID: 4205464
    [No Abstract]   [Full Text] [Related]  

  • 37. The principles of pharmacology (3).
    Hood P
    Br J Theatre Nurs; 1997 Mar; 6(12):15-6, 20-2. PubMed ID: 9146136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphologic and clinical effect of pyrimethamine-sulfonamide combinations (sulformethoxine-pyrimethamine or sulfamonomethoxine-pyrimethamine) on P. vivax and its infection.
    Ebisawa I; Komoriya T; Kimura M; Muto T
    Jpn J Exp Med; 1974 Apr; 44(2):151-63. PubMed ID: 4601054
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical trial of the antibacterial combination sulfamoxole/trimethoprim (CN 3123). 1st communication. Efficacy activity spectrum--resistance in therapy (author's transl)].
    Etzel M; Wesenberg W
    Arzneimittelforschung; 1976; 26(42):661-5. PubMed ID: 782474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Injectable corticotherapy in otorhinolaryngology (apropos of 385 cases). Respective indications of 2 derivatives, one with quick action, the other with delayed action. Respective indications of general and local administration].
    Mounier-Kuhn P; Gaillard J; Morgon A; Charachon R; Haguenauer JP; Muguet D; Fontvieille J
    Lyon Med; 1971 Feb; 225(4):357-61. PubMed ID: 5088601
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.